T1	Participants 180 210	patients with Behcet's disease
T2	Participants 71 101	patients with Behcet's disease
T3	Participants 235 326	total of 67 eyes of 35 Behcet's patients with chronic, but well-controlled uveitis, and CMO
T4	Participants 756 797	29 patients (55 eyes) completed the trial
T5	Participants 831 866	Of the 29, 16 men and 13 were women
T6	Participants 868 916	The age range was 13-50 years (mean 33.6 years).
T7	Participants 917 942	Patients on acetazolamide
T8	Participants 1685 1711	Behcet's patients with CMO
